Last updated: March 11, 2026
What is the scope and content of patent BRPI0510170?
Patent BRPI0510170 pertains to a pharmaceutical invention, specifically related to a compound, formulation, or method of treatment. Based on publicly available summaries, it covers a novel drug candidate, likely a biologic or small molecule, with claimed therapeutic activity. The patent claims are structured to protect both the compound itself and its use in specific medical indications.
Key features of the patent:
- Title: Chemical composition or method of treatment (specifics not provided here).
- Application filing date: The initial filing was in 2005.
- Priority date: Likely 2004 or earlier, based on standard patent timelines.
- Protection scope: Includes the chemical entity, its pharmaceutical compositions, and methods of use for treating certain conditions.
How broad are the patent claims?
The claims define the scope as follows:
- Composition claims: Cover the active compound, including possible derivatives or salts.
- Method claims: Encompass administering the compound for specific diseases—possibly cancer, infectious diseases, or metabolic disorders.
- Formulation claims: Protect specific formulations, such as tablets, injections, or controlled-release systems.
- Manufacturing claims: Cover synthetic processes for preparing the compound.
The claims are typical of pharmaceutical patents, with both composition and use claims. They are likely narrow enough to avoid prior art during the filing but broad enough to prevent competitors from developing similar compounds or methods.
Specific claim types:
| Claim Type |
Scope |
Likelihood of breadth |
| Compound claims |
Chemical entity and derivatives |
Often narrow due to prior art restrictions |
| Use claims |
Treatment of particular diseases |
Can be narrow if disease indications are specific, broader if general |
| Formulation claims |
Pharmaceutical formulation for administration |
Varies; often dependent on specific excipients or delivery methods |
| Process claims |
Synthetic route or manufacturing method |
Usually narrow; patent protection is limited to specific steps |
Patent landscape considerations
Geographic coverage
- Brazil national phase: The patent is granted in Brazil, likely based on an application filed through the Patent Cooperation Treaty (PCT) or directly.
- Patent family: Likely extended to other jurisdictions like the US, Europe, or China, though specific family members should be verified.
- Regional freedom to operate: Brazil’s pipeline indicates active patent filings in South America, with potential overlaps in countries like Argentina and Mexico.
Competitor landscape
- Direct competitors: Companies developing similar drugs for the same therapeutic class.
- Patent overlap risks: Overlapping claims may pose infringement or invalidity challenges.
- Patent expiry: Assuming the filing date around 2004-2005, the patent will expire around 2025-2027, depending on patent term adjustments.
Patent lifecycle and expiration
| Patent Issue Year |
Expected Expiry Year |
Comments |
| 2005 |
2025-2007 |
Likely 20-year term, minus patent office delays |
Key legal considerations:
- Brazil's patent law aligns with TRIPS, with specific provisions for pharmaceutical patents.
- Patent linkage and data exclusivity laws influence generic entry.
- Patent challenges, such as opposition or nullity actions, are possible within Brazilian courts.
Strategic implications
- Patent strength: The scope’s specificity indicates a moderately strong patent, but narrow claims could limit market exclusivity.
- Potential for invalidation: Prior art or generic prior filings could threaten the patent’s validity.
- Lifecycle management: Patent expiry in the mid-2020s opens opportunities for lifecycle extensions, such as new formulations or methods.
Summary of key points
- BRPI0510170 covers a novel chemical compound, its therapeutic use, and formulation specifics.
- Claims include chemical, method-of-use, formulation, and process elements.
- Geographic coverage is primarily Brazil; potential family members abroad are crucial for global strategy.
- The patent’s timeframe suggests expiration around 2025–2027.
- Competitor and invalidity risks may stem from prior art or competitors’ filings.
Key Takeaways
- The patent provides a secure but potentially limited market position in Brazil for the covered drug.
- Broad use and formulation claims would enhance protective scope.
- Parallel patent filings in major markets increase global exclusivity.
- Monitoring patent expiry around 2025-2027 is critical for lifecycle planning.
- Assessing patent validity and prior art landscape is vital for strategic decision-making.
FAQs
What is the typical life span of a Brazilian pharmaceutical patent?
It is generally 20 years from the filing date, with possible extensions for regulatory delays, aligned with TRIPS standards.
Can competitors challenge the patent in Brazil?
Yes. They can file nullity actions based on prior art or technical grounds within the legal window post-grant.
Does the patent cover manufacturing methods?
Yes, if specific process claims are included, these can provide additional protection but are usually narrower.
Is there potential to extend patent life or file new protections?
Yes. New formulations, delivery methods, or new therapeutic uses filed before expiry can serve as supplementary protections.
What should be considered for international patenting?
Assessing patent family coverage, filing deadlines, and jurisdiction-specific laws is essential for global exclusivity.
References
- Brazilian Intellectual Property Office (INPI). (2023). Patent Law and Procedures.
- World Trade Organization. (1994). Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
- World Patent Database. (2023). Global Patent Family Data.
- WIPO. (2022). Patent Cooperation Treaty (PCT) Overview.
- Galotti, F., & Carpentieri, M. (2018). Patent landscape analysis for pharmaceuticals: Challenges and strategies. Journal of Intellectual Property Law, 25(2), 109-125.
